While germline RB1 mutations can be isolated from the peripheral blood and used to stratify the risk of second ocular and non-ocular tumors for patients with heritable disease, this has little to no impact on the diagnosis of retinoblastoma, nor on the prognostication for globe salvage. The gene discussed is RB1; the disease is eye neoplasm.